Diabetes in Urban African-Americans. IX. Provider Adherence to Management Protocols
- 1 May 1997
- journal article
- research article
- Published by American Diabetes Association in Diabetes Care
- Vol. 20 (5), 698-703
- https://doi.org/10.2337/diacare.20.5.698
Abstract
OBJECTIVE Staged diabetes management should permit glycemic goals to be attained in a timely manner, but the success of such an approach requires conformity by health care providers. To test performance, we analyzed the adherence of practitioners to a protocol for staged management of NIDDM patients. RESEARCH DESIGN AND METHODS Records of patients treated at the Grady Memorial Hospital Diabetes Clinic were reviewed retrospectively over a 3-year period. For each patient, intensification of therapy was indicated if fasting plasma glucose was > 7.8 mmol/l and a prior HbA1c was > 7.0%. Protocols dictated a progression from dietary therapy alone to increasing dosages of sulfonylureas to increasing dosages of insulin. Patients were seen at bimonthly intervals. RESULTS During the 3-year period, 1,051 patient visits met protocol criteria for intensification. Adherence to the protocol improved significantly in the 3rd year compared with the first 2 years (30, 31, and 47% adherence in the 1st, 2nd, and 3rd years, respectively). Patients treated with diet alone were significantly less likely to have their therapy intensified than patients on sulfonylureas or insulin (intensification rates 25, 41, and 47%, respectively). In the management of patients treated with diet alone, practitioners were reluctant to intensify therapy at early visits, but were more likely to do so later, 19% of patients beyond goal range at the 2-month visit were started on pharmacological therapy vs. 28% at the 4-month visit, and 39% at the 6-month visit (P < 0.01). In contrast, there was no significant difference in the frequency of therapy intensification between early and late visits for patients on sulfonylureas or insulin. Practitioners appeared to base the decision to intensify on the fasting plasma glucose level more than on the most recent HbA1c. Age did not appear to be a significant factor in the decision to intensify. CONCLUSIONS Although staged management protocols constitute critical tools to achieve glycemic goals, the adherence of health care providers may be suboptimal. Special efforts may be needed to assure compliance.This publication has 11 references indexed in Scilit:
- The Feasibility of Intensive Insulin Management in Non-Insulin-dependent Diabetes Mellitus: Implications of the Veterans Affairs Cooperative Study on Glycemic Control and Complications in NIDDMAnnals of Internal Medicine, 1996
- Forum One: Current Recommendations about Intensification of Metabolic Control in Non-Insulin-dependent Diabetes MellitusAnnals of Internal Medicine, 1996
- OUTCOMES OF PATIENTS WITH HYPERTENSION AND NON-INSULIN-DEPENDENT DIABETES-MELLITUS TREATED BY DIFFERENT SYSTEMS AND SPECIALTIES - RESULTS FROM THE MEDICAL OUTCOMES STUDY1995
- Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes (VA CSDM): Results of the feasibility trialDiabetes Care, 1995
- Safety and Efficacy of Normalizing Fasting Glucose With Bedtime NPH Insulin Alone in NIDDMDiabetes Care, 1995
- Clinical Management of the NIDDM Patient: Impact of the American Diabetes Association Practice Guidelines, 1985–1993Diabetes Care, 1995
- Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year studyDiabetes Research and Clinical Practice, 1995
- Health care expenditures for people with diabetes mellitus, 1992.Journal of Clinical Endocrinology & Metabolism, 1994
- Lymphocytic Infundibuloneurohypophysitis as a Cause of Central Diabetes InsipidusNew England Journal of Medicine, 1993
- The Wisconsin Epidemiologic Study of Diabetic RetinopathyArchives of Ophthalmology (1950), 1984